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To determine the prevalence of cardiac abnormalities in 
patients with human immunodeficiency virus (HIV) infec- 
tion, two-dimensional Doppler echocardiography was per- 
formed on 70 consecutive patients with HIV infection, 
including 51 with acquired immunodeficiency syndrome 
(AIDS), 13 with AIDS-related complex and 6 with asymp 
tomatic HIV infection. Of the 70 patients, 36% were 
hospitalized and 64% were ambulatory at the time of 
evaluation. The average age was 37 years; 93% were 
homosexual men. 
Echocardiographic findings included dilated cardiomy- 
opathy in eight patients (ll%), pericardial effusions in 
seven patients (10%) (one with impending tamponade), 
pleural effusion in four patients (6%) and mediastinal mass 
in one patient (1%). Among the 25 hospitalized patients, 
echocardiographic abnormalities were noted in 16 (64%), 
whereas among the 45 ambulatory patients, the only ab- 
With the increasing prevalence of acquired immunodefi- 
ciency syndrome (AIDS) and human immunodeficiency vi- 
rus (HIV) infection, varied clinical manifestations of disease, 
including cardiac involvement, have been noted (l-11). 
Although pathologic studies and case reports of AIDS pa- 
tients with dilated cardiomyopathy (l-7), pericardial effusion 
(7,8), Kaposi’s sarcoma (9) and opportunistic infections 
(10,ll) involving the heart have been described, the preva- 
lence of cardiac abnormalities in living adults with HIV 
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normality noted was mitral valve prolapse in 3 patients 
(7%) (p < 0.0001). Dilated cardiomyopathy was the only 
echocardiographic lesion more common in the 25 hospital- 
ized patients than in 20 hospitalized control patients with 
acute leukemia. Symptoms of congestive heart failure re- 
sponded to conventional therapy. Cardiac lesions were 
associated with active Pneumocystis carinii pneumonia and 
low T helper lymphocyte counts. 
Dilated cardiomyopathy of unknown origin may be 
more common than was previously recognized in hospital- 
ized, acutely ill patients with AIDS, but is uncommon in 
ambulatory patients with HIV infection. Echocardiography 
should be considered in the evaluation of dyspnea in 
hospitalized patients with HIV infection, especially those 
with dyspnea that is out of proportion to the degree of 
pulmonary disease. 
(J Am Co11 Cardiol1989;13:1030-6) 
infection is unknown. To better define this prevalence, relate 
cardiac abnormalities to other manifestations of HIV- 
associated disease and compare the prevalence of cardiac 
abnormalities in hospitalized and ambulatory patients, we 
performed two-dimensional echocardiography with Doppler 
ultrasound studies on a series of consecutive patients with 
HIV infection. 
Methods 
Patient selection (Table 1). The study protocol was ap- 
proved by the Committee for Human Research at the Uni- 
versity of California, San Francisco. From September 1987 
to September 1988, 82 consecutive patients from the AIDS 
clinic with known HIV infection were asked to participate in 
the study; of these patients, 70 (85%) were evaluated. Of the 
70 study patients, 25 (36%) were hospitalized and 45 (64%) 
were ambulatory at the time of evaluation. There was no 
clinical or radiographic suspicion of cardiac disease in the 
ambulatory patients, all of whom were examined by one of 
the authors (D.N.C., H.H.). One patient with left ventricular 
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Table 1. Clinical Manifestations of Human Immunodeficiency 
Virus (HIV) Infection in 70 Patients 
Hospitalized Ambulatory 
HIV HIV Control 
No. of patients 
Age (yr) 
Weight (kg) 
IBW (%l 
Systolic BP (mm Hg) 
Diastolic BP (mm Hgl 
Serum albumin tgiliterlt 
Hematocrit 
T4 cell count (X 10h/litert 
Major infections 
Pneumoryslis cclrinii 
Cytomegalovirus 
Mycobacterial disease 
Bacterial sepsis 
Disseminated fungal disease 
Neoplasms 
Kaposi’s sarcoma 
Lymphoma 
Zidovudine (AZT) therapy 
25 45 20 
35 ? 5 37 + 7 362 IO 
64 + 8 73 ? 9” 692 I! 
962 14 IO? 2 I6 I03 + I3 
992 I? II3 + II* II7 i 19* 
63 2 II 73 ? 8* 702 IO 
23 + 4 35 2 t3* 27 + 5 
0.31 i- 0.6 0.37 ? O.h* 0.29 2 0.5 
131 t I86 333 c 217” NA 
I8 14* 
2 5 
3 I 
1 0 
I 0 
6 5 
II I4 
I* 
0* 
0 
0” 
*p < 0.05 versus hospitalized patients with HIV: fconversion factor to 
mgidl is 0.1. AIDS = acquired immunodeficiency syndrome: BP = blood 
pressure: IBW = predicted ideal body weight: NA = not available. 
dysfunction and known significant left main coronary artery 
disease was excluded from the study. 
Diagnoses according to criteria from the Centers for 
Disease Control (12) included AIDS in 51 patients, AIDS- 
related complex in 13 and asymptomatic HIV infection in 6. 
Of the 70 study patients, 43 (61%) had an AIDS-defining 
opportunistic infection, 12 (17%) had an AIDS-defining 
malignancy and 7 (10%) had both. The average age was 37 
years (range 23 to 54); all but 3 patients were male. Risk 
factors for HIV infection included homosexuality in 65 
patients (93%), blood transfusion in 3 (4%) intravenous drug 
abuse in 3 (4%) and heterosexual contact in 2 (3%); 4 patients 
had more than one risk factor. Clinical manifestations of 
HIV infection are listed in Table 1. Zidovudine (AZT) was 
being administered to 25 patients (36%) in the study, includ- 
ing 11 hospitalized patients. 
Control patients (Table 1). The control patients were 
identified from a retrospective review of hospitalized pa- 
tients with acute leukemia between the ages of 20 and 55 
years who underwent echocardiography as a baseline test 
before the initiation of chemotherapy or bone marrow trans- 
plantation between 1982 and 1987. Hematologic diagnoses 
were based on the results of bone marrow biopsy in all 
patients; patients who were treated with anthracycline de- 
rivatives before the echocardiogram were excluded. Twenty 
patients who met these criteria served as control patients. 
Their mean age was 36 years, and 15 patients were male. 
Hematologic diagnoses were acute myelogenous leukemia in 
12. accelerated phase of chronic myelogenous leukemia in 5 
and acute lymphocytic leukemia in 3. Clinical information on 
these patients is listed in Table 1. 
Chart review. Hospital and clinic charts on all study and 
control patients were reviewed for the following informa- 
tion: height and weight at the time of evaluation, physical 
examination, medications, opportunistic infections, serum 
albumin. hematocrit. chest radiograph and electrocardio- 
gram (ECG). For study and control patients, predicted ideal 
body weight was also calculated. 
T4 lymphocyte counts. T4 lymphocyte cell counts were 
performed on 60 of the HIV-infected patients. Lymphocytes 
expressing the T4 antigen (helper/inducer ceils) were enu- 
merated with the use of simultaneous dual immunofluores- 
cence and flow cytometry (Becton-Dickinson Immunocyto- 
metry Systems) with mixed monoclonal antibodies (13). T4 
lymphocyte counts in normal adult range from 459 to 1.535 X 
lO?liter by this technique in this laboratory. 
Echocardiogruphy 
Imaging technique. Quantitative M-mode, two-dimen- 
sional and Doppler echocardiograms were performed on a 
phantom-calibrated IREX Meridian ultrasound machine. 
The subjects were placed in the 90” left lateral decubitus 
position, left ventricular chamber sizes were maximized in 
standard views and respiration was suspended before re- 
cording (14). Blood pressure was determined by sphygmo- 
manometer at the end of the echocardiographic study with 
the patient seated. 
Measurements and tracing. Echocardiographic measure- 
ments were made on a phantom-calibrated Diasonics com- 
puter-guided light-pen digitizing system. End-diastolic areas 
were traced on video frames at the peak of the R wave on the 
ECG or just after mitral valve closure; end-systolic areas 
were traced at the frame immediately preceding mitral valve 
opening. 
Morphology. Mitral-septal separation was defined by M- 
mode echocardiography as the perpendicular distance be- 
tween the E point of the anterior mitral leaflet and a tangent 
drawn to the most posterior point reached by the interven- 
tricular septum within the same cycle (15). Mitral-septal 
separation was measured at a level in which both mitral 
leaflets were well seen. 
Average diastolic left ventricular wall thickness and left 
ventricular mass were calculated with use of a truncated 
ellipsoid formula (16). Previous work (17) indicates that 
mean left ventricular mass index by this technique in a 
normal adult man is 71 g/m’; the upper limit of normal is 94 
g/m’. 
Left ventricular volumes and ejection fraction were mea- 
sured using a modification of Simpson’s rule (18-20). End- 
systolic and end-diastolic endocardial areas were traced in 
the apical two and four chamber views to generate left 
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ventricular end-diastolic volume, end-systolic volume and 
ejection fraction. According to previous work (20), mean left 
ventricular end-diastolic volume index by this technique in a 
normal adult man is 58 ml/m*; the upper limit of normal is 80 
ml/m’. 
Dilated cardiomyopathy was defined as the presence of 
diffuse left ventricular hypokinesia (ejection fraction ~45%) 
and left ventricular dilation (left ventricular end-diastolic 
volume index >80 ml/m*). 
Doppler evaluation. Standard Doppler evaluations of all 
four cardiac valves in pulsed wave and continuous wave 
modes were performed. The presence and severity of valvu- 
lar regurgitation were determined by standard methods (21). 
Doppler focalization of tricuspid insuficiency was per- 
formed in the pulsed mode, then maximized and measured in 
the continuous wave mode. By a modification of the Ber- 
noulli formula (22), the peak pressure gradient (in mm Hg) 
between the right atrium and ventricle was estimated as the 
product of 4 and maximal tricuspid insufficiency velocity 
squared (AP = 4V*). Right ventricular systolic pressure was 
computed as the sum of this pressure gradient and right atria1 
pressure (right ventricular systolic pressure = 4V2 + right 
atria1 pressure) (23). Subcostal views in all but four patients 
demonstrated >50% collapse of the diameter of the proximal 
inferior vena cava during deep inspiration. Right atria1 
pressure was assumed to be 5 mm Hg for these patients and 
15 mm Hg for the four patients with ~50% collapse of the 
inferior vena cava (24,25). By this method, the upper limit of 
normal for right ventricular systolic pressure in this labora- 
tory is 30 mm Hg. 
Statistical analysis. Data were evaluated by chi-square 
analysis and factorial analysis of variance. Upper limits of 
normal for left ventricular mass index and end-diastolic 
volume index in normal men determined in this laboratory 
(listed earlier) have previously been computed and reported 
(17,20) as the 90% upper confidence bounds for the 95th 
percentile. Comparisons were made between hospitalized 
and ambulatory patients with HIV infection and between 
hospitalized patients with HIV infection and control pa- 
tients. Values are listed as mean ? standard deviation (SD). 
The null hypothesis was rejected at the 5% level. 
Results 
Clinical Data (Table 1) 
Among the 70 patients with HIV infection, 25 were 
hospitalized and 45 were ambulatory at the time of evalua- 
tion. 
Ambulatory versus hospitalized with HIV infection. Com- 
pared with the ambulatory patients, the hospitalized patients 
more frequently had a history of Pneumocystis carinii pneu- 
monia and had significantly lower mean values for body 
weight, systolic and diastolic blood pressure, serum albu- 
min, hematocrit and T4 lymphocyte count. 
Table 2. Echocardiographic Findings in 70 HIV-Infected Patients 
Hospitalized HIV Ambulatory HIV Control 
No. of patients 25 (24) 45 (27) 20 
Dilated cardiomyopathy 8 (7) 0* 0* 
Pericardial effusion 7 (7) 0* 6 
Pleural effusion 4 (3) 0% 2 
Mediastinal mass I (1) 0 0 
Mitral valve prolapse 0 3 (1) I 
*p < 0.05 versus hospitalized patients with HIV; numbers in parentheses 
indicate patients with AIDS as opposed to AIDS-related complex or asymp- 
tomatic HIV infection. HIV = human immunodeficiency virus. 
Hospitalized patients with HIV infection versus control 
patients. The control patients with acute leukemia and the 
hospitalized patients with HIV infection were similar in 
mean age, body weight, percent of ideal body weight, 
diastolic blood pressure, serum albumin and hematocrit. 
However, control patients had significantly higher values for 
systolic blood pressure. Compared with control patients, 
hospitalized patients with HIV infection also more fre- 
quently had a history of Pneumocystis carinii pneumonia, 
Kaposi’s sarcoma and treatment with AZT. 
Two-Dimensional Echocardiographic Findings 
(Table 2) 
Echocardiographic lesions. Two-dimensional echocar- 
diography demonstrated dilated cardiomyopathy, pericardial 
effusion, pleural effusion or mediastinal mass in 16 (64%) of 
the 25 hospitalized patients with HIV infection. In compar- 
ison, mitral valve prolapse was the only abnormality noted in 
3 (7%) of the 45 ambulatory patients (p < 0.0001). 
Of the echocardiographic lesions, only dilated cardiomy- 
opathy was significantly more common in hospitalized pa- 
tients with HIV infection than in control patients with acute 
leukemia. Dilated cardiomyopathy was demonstrated in 
eight study patients with HIV infection versus no control 
patient (p < 0.05), pericardial effusion in seven study pa- 
tients versus six control patients (p = NS), pleural effusion 
in four study patients versus two control patients (p = NS) 
and mediastinal mass in one study patient versus no control 
patients (p = NS). All of these echocardiographic lesions 
were limited to patients with AIDS, except for one patient 
with AIDS-related complex who had dilated cardiomyopa- 
thy and a pleural effusion. 
Dilated cardiomyopathy. Among the eight hospitalized 
patients with HIV infection and dilated cardiomyopathy, 
four were detected from the clinical evaluation and four were 
first recognized at the time of the echocardiogram. All eight 
patients had four chamber enlargement and diffuse left 
ventricular hypokinesia, with a mean ejection fraction of 33 
+ 13% (range 10 to 45%), end-diastolic volume index of 96 f 
40 ml/m* and left ventricular mass index of 108 + 23 g/m* 
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Figure 1. Comparison, of left ventricular (LV) ejection fractions and 
end-diastolic volume indexes by two-dimensional echocardiography 
in 25 hospitalized patients with HIV infection, 45 ambulatory 
patients with HIV infection and 20 control patients with acute 
leukemia. The eight patients with dilated cardiomyopathy are indi- 
cated by black circles in the first column; the other 17 hospitalized 
patients by open circles. Horizontal bars indicate mean values. “p < 
0.05 versus hospitalized patients with HIV infection. NS = no 
significant difference versus the same group. 
(Fig. I). Two patients presented with congestive heart failure 
at the time of a first AIDS-defining opportunistic infection: 
five other patients had previously known AIDS and one had 
previously known AIDS-related complex. 
None of the patients with cardiomyopathy had had prior 
administration of cardiotoxic medications or a history of 
alcohol abuse, hypertension, diabetes or coronary disease: 
however, two patients did have a history of intravenous drug 
abuse and one had concomitant hepatic and renal failure. 
Two patients with AIDS who did not have cardiomyopathy 
were treated with anthracycline derivatives for Kaposi’s 
sarcoma. Among the eight patients with cardiomyopathy, 
five had active Pnrumocystis cavinii pneumonia, one had 
Kaposi’s sarcoma, one had tuberculosis and one had bacte- 
rial pneumonia; four patients with cardiomyopathy were 
receiving AZT therapy. The four patients with symptoms of 
congestive heart failure were successfully palliated with 
diuretic drugs, digoxin and an angiotensin-converting en- 
zyme inhibitor. At 6 months follow-up after echocardiog- 
raphy, four of the patients with cardiomyopathy have died 
(two of progressive hypotension and dyspnea attributed to 
cardiac failure. and two of respiratory failure due to Pneu- 
moc~stis carinii pneumonia). Autopsy in one patient re- 
vealed dilated cardiomyopathy without evidence of inflam- 
matory myocarditis or cardiac opportunistic infection. 
Pericardial effusion. In the seven patients with pericar- 
dial effusion, no effusion was suspected clinically. One of the 
seven patients had a moderate-sized effusion associated with 
mild right atrial collapse. consistent with impending tampo- 
nade (26): the patient refused pericardiocentesis and was 
treated with a nonsteroid anti-inflammatory drug. Follow-up 
study revealed a significant decrease in the size of the 
pericardial effusion with resolution of right atria1 collapse. 
The other six patients had a small pericardial effusion 
without clinical or echocardiographic evidence of hemody- 
namic compromise. Among the seven patients, six were 
hospitalized for treatment of active Pneumocystis carinii 
pneumonia. one had a previous history of this infection, two 
had a history of Kaposi’s sarcoma, one had pulmonary 
tuberculosis and one had non-Hodgkin’s lymphoma; three of 
the patients also had dilated cardiomyopathy. The mean 
serum albumin concentration in these seven patients was 25 
g/liter (2.5 gidl); the lower limit of normal in this laboratory 
is 33 g/liter (3.3 gidl). 
Pleural effusion. In the four patients with pleural effusion 
by echocardiography (two with a large left pleural effusion, 
one with a small right effusion and one with a small bilateral 
effusion), the effusion had been previously documented by 
chest radiograph with decubitus films. Manifestations of 
AIDS in these four patients included Pneumocystis carinii 
pneumonia in three, mycobacterial infection in two, cardio- 
myopathy in two and Kaposi’s sarcoma in one. In the two 
patients with a large effusion and dyspnea, thoracentesis was 
performed. with sympomatic benefit. 
Mediastinal mass. One patient who had lymphadenopa- 
thic Kaposi’s sarcoma presented with dyspnea and de- 
creased exercise tolerance. Echocardiography showed an 8 
cm anterior mediastinal mass that compressed the right 
ventricle. Computed tomography confirmed the presence of 
a water density mass and also revealed diffuse mediastinal 
and axillary lymphadenopathy. Biopsy of the mediastinal 
mass was declined. 
Doppler findings. Comparison of the hospitalized and 
ambulatory patients with HIV infection revealed no signifi- 
cant differences in the incidence of regurgitation of the mitral 
(52% versus 45%). tricuspid (74% versus 67%) or aortic (4% 
versus 0%) valve. respectively (all p = NS). Although no 
patient in the study had severe mitral or tricuspid insuffi- 
ciency, the eight patients with dilated cardiomyopathy usu- 
ally had mild to moderate valvular regurgitation by Doppler 
study that was associated with a murmur on physical exam- 
ination. whereas the other patients had absent, trivial or mild 
regurgitation that was usually not associated with a murmur. 
Peak pulmonary systolic pressure was significantly higher in 
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Table 3. Echocardiographic Measurements in 70 
HIV-Infected Patients 
Hospitalized HIV Ambulatory HIV 
(n = 25) (n = 45) 
E point (cm) 0.9 t 0.6 
LVEDVI (ml/m’) 61 2 29 
LVESVI (ml/m’) 34 ? 23 
LVEF (%) 542 18 
LVMI (g/m’) 78 2 24 
AWT (cm) I.1 2 0.2 
LAVI (ml/m’) 43 * 21 
0.4 ? 0.1* 
50 + l6* 
20 ? 6* 
60 ? 8 
67 + 21 
0.9 2 0.3* 
34 2 10” 
Control 
(n = 20) 
0.5 ? 0.2* 
51 ? 15* 
24 i 7* 
61 ? IO 
72 ? 25 
I.1 + 0.2 
34 r 9” 
*p < 0.05 versus patients hospitalized with HIV. AWT = average 
diastolic left ventricular wall thickness; E point = mitral-septal separation: 
HIV = human immunodeficiency virus: LAVI = left atrial volume index; 
LVEDVI = left ventricular end-diastolic volume index: LVEF = left ventric- 
ular ejection fraction; LVESVI = left ventricular end-systolic volume index: 
LVMI = left ventricular mass index. 
hospitalized than in ambulatory patients with HIV infection 
(37 ? 11 versus 22 ? 4 mm Hg, respectively, p < 0.05). 
Quantitative Planimetry (Table 3) 
Hospitalized versus ambulatory patients with HIV infection 
(Fig. 1). Compared with the ambulatory patients with HIV 
infection, hospitalized patients with HIV infection had sig- 
nificantly higher echocardiographic values for mean mitral- 
septal separation, left ventricular end-diastolic and end- 
systolic volume indexes, average wall thickness and left 
atria1 volume index (Fig. 1). There were no significant group 
differences for mean left ventricular ejection fraction or mass 
index. 
Hospitalized patients with HIV infection versus control 
patients (Fig. 1). Compared with control patients, hospital- 
ized patients with HIV infection also had significantly higher 
values for mitral-septal separation, left ventricular end- 
diastolic and end-systolic volume indexes and left atria1 
volume index. Mean left ventricular ejection fraction, mass 
index and average wall thickness were not significantly 
different between these two groups. 
Discussion 
To determine the prevalence of cardiac lesions, we eval- 
uated a series of HIV-infected patients by two-dimensional 
echocardiography with Doppler ultrasound. The patients in 
the study were mainly symptomatic homosexual men. Of the 
70 study patients with HIV infection, eight (11%) were found 
to have dilated cardiomyopathy, seven (10%) had pericardial 
effusion, four (6%) had pleural effusion and one (2%) had a 
mediastinal mass. 
Selection of control patients. Although it is difficult to 
select an appropriate control group for adults hospitalized 
with AIDS, we chose young patients with acute leukemia 
who had baseline echocardiography before the administra- 
tion of anthracycline derivatives. Like the hospitalized HIV- 
infected patients, the control patients were relatively young 
and systemically ill. Of the echocardiographic lesions dem- 
onstrated, only dilated cardiomyopathy was statistically 
more common in hospitalized patients with HIV infection 
than in control patients. These results in consecutively 
studied patients, plus the diagnosis of dilated cardiomyopa- 
thy in four other patients with AIDS in this laboratory over 
the 3 years before this study, suggest an association between 
dilated cardiomyopathy and AIDS. 
Comparison with previous reports. The prevalence of 
dilated cardiomyopathy in this study was nearly identical to 
that in a recent necropsy series of patients with AIDS (2). 
Pericardial tamponade has also been reported previously in 
patients with AIDS (7). One of our seven patients with 
pericardial effusion had incipient tamponade that improved 
after therapy with a nonsteroid anti-inflammatory drug; the 
remaining six patients had a small, hemodynamically insig- 
nificant effusion. The origin of the pericardial effusion in this 
study was not clear; however, hypoalbuminemia and contig- 
uous pneumonitis may have been contributing factors. We 
have previously described (27) a patient with AIDS with a 
large mediastinal mass. 
Findings in hospitalized versus ambulatory patients. We 
observed a striking difference in the incidence and severity 
of echocardiographic findings between hospitalized and am- 
bulatory patients with HIV infection. Among the 25 hospi- 
talized HIV-infected patients, cardiac and thoracic abnor- 
malities were noted in 16; in contrast, among the 45 
ambulatory patients, the only abnormality noted was mitral 
valve prolapse in three patients. Our data in living subjects 
confirm previous pathologic reports (l-5) that dilated cardio- 
myopathy and other cardiac abnormalities are fairly com- 
mon in hospitalized, acutely ill patients with AIDS. How- 
ever, we have also shown that cardiac lesions are uncommon 
in ambulatory patients with HIV infection, despite prior 
major opportunistic infections in one-third of patients. 
Comparing the hospitalized with the ambulatory patients 
with HIV infection, the former had larger, thicker hearts and 
higher peak pulmonary systolic pressures. The differences 
between these groups were mainly due to the hospitalized 
patients with dilated cardiomyopathy. Although hospitalized 
patients had a lower hematocrit than ambulatory patients, 
cardiac enlargement has been reported (28) to develop only 
in association with severe anemia. Left ventricular hyper- 
trophy could not be attributed to hypertension because 
hospitalized patients had significantly lower values for sys- 
tolic and diastolic blood pressure than did outpatients with 
HIV infection or control patients. 
In the ambulatory HIV-infected study patients, values for 
mean left ventricular mass and end-diastolic volume were 
lower than normal, but still in the normal range reported for 
healthy adult men (17,20). After correction for body surface 
JACC Vol. 13. No. 5 
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area, these variables were closer to mean normal values: 
thus, we attributed this difference in cardiac size to cachectic 
habitus. Mild or moderate pulmonary hypertension was 
noted in the patients with dilated cardiomyopathy and in two 
additional hospitalized patients who had active Pneumocy- 
stis carinii pneumonia. 
Prognosis of dilated cardiomyopathy. Among the eight 
HIV-infected patients with dilated cardiomyopathy, four had 
a rapidly fatal acute course. Despite this poor outcome, 
symptoms of congestive heart failure due to dilated cardio- 
myopathy often initially responded to conventional treat- 
ment. Therapy with AZT did not appear to prevent the 
development of cardiomyopathy because four of the eight 
patients had been given this drug. 
Pathogenesis of dilated cardiomyopathy. The history of 
each patient with cardiomyopathy was negative for exposure 
to known cardiotoxins. AZT and trimethoprim-sulfamethox- 
azole, the two most commonly administered drugs in this 
study, have not been reported to cause myocarditis or 
congestive heart failure in AIDS or non-AIDS patients 
(29,30). Although many of the hospitalized patients with 
AIDS were underweight or even cachectic at the time of 
evaluation. nutritional deficiency seems unlikely as an etio- 
logic factor, since hospitalized patients with HIV infection 
and control patients were comparably abnormal in percent of 
predicted ideal body weight and serum albumin. Similar to 
previous studies (l-7). the patients studied were nearly all 
homosexual men without a history of intravenous drug 
abuse. Thus, cardiac abnormalities associated with addic- 
tion. such as valve vegetations. valvular sclerosis and car- 
diac abscesses. were not demonstrated. It is unknown 
whether patients with AIDS secondary to intravenous drug 
abuse have a greater or lesser incidence of cardiac lesions, 
including dilated cardiomyopathy. 
We ,foand an associution hct\z~een the presence of active 
Pneumocystis carinii pnerrmonia infection and card& ah- 
normalities. Neither the organism nor the drugs employed in 
treatment have been reported to cause myocarditis or myo- 
cardial depression. There was no correlation with other 
active opportunistic infections such as cytomegalovirus. We 
speculate that the most immunologically compromised pa- 
tients with AIDS may be predisposed to develop multiple 
complications of immunocompromise, including myocar- 
ditis. Although this concept is supported by significantly 
lower T4 cell counts in hospitalized than in ambulatory study 
patients with HIV infection (31). T4 counts did not differ 
between patients with dilated cardiomyopathy and other 
hospitalized patients with HIV infection. 
Recent reports (l-7) saggest that the most likely origin of 
dilated cardiomyoptrth.v in patients with HIV infection is 
in,f&tious myocarditis. Several autopsy studies in adult and 
pediatric patients with AIDS (l-5) have demonstrated that 
focal myocarditis is a common and often asymptomatic 
cardiac lesion. Although various cardiac pathogens have 
HIMELMAN ET AL. 1035 
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been identified by necropsy in patients with AIDS (including 
cytomegalovirus, Toxoplasma gondii, Crq’tococcus neofor- 
mans, Candida al&cans, Myohacterium tuberculosis and 
Histoplasma caps&turn), there is no clear relation between 
the presence of an opportunistic pathogen and the severity of 
myocarditis (3). Alternatively, myocardial dysfunction may 
be caused by direct myocyte infection by HIV. In one report 
(32). HIV was cultured from an endomyocardial biopsy 
sample in a living patient with myocarditis. Our findings in 
patients with dilated cardiomyopathy are limited by the lack 
of myocardial tissue by either endomyocardial biopsy or 
autopsy. Further clinicopathologic research is required to 
confirm the diagnoses and provide information about the 
pathogenesis of the disease. 
Clinical implications. Many patients with AIDS develop 
multiple opportunistic pulmonary infections, so that dyspnea 
is often assumed to be of pulmonary origin. Our findings 
suggest that cardiac abnormalities should also be considered 
in the evaluation of dyspnea in these patients. Palliative 
therapy for dyspnea due to congestive heart failure or 
pericardial effusion in this setting is efficacious, and differs 
from therapy for pulmonary processes. In addition, the 
detection of occult cardiomyopathy in AIDS may have 
relevance for the choice of antibiotic and tumor therapy. For 
example, intravenous trimethoprim-sulfamethoxasole must 
be administered in a large volume of fluid to avoid crystalli- 
zation of drug in the renal tubules (33); this fluid load might 
not be well tolerated by a patient with cardiac compromise. 
Likewise. anthracycline derivatives, which are used as che- 
motherapeutic agents for Kaposi’s sarcoma. could lead to 
further deterioration of cardiac function if administered to a 
patient with cardiomyopathy. The use of echocardiography 
should be considered in the evaluation of dyspnea in hospi- 
talized patients with AIDS, especially those who have short- 
ness of breath that is out of proportion to their diagnosed 
pulmonary disease. 
We are indebted to Salvatore Geraci. RDMS for performing most of the 
echocardiographic studies. and to Melvin Cheitlin. MD and Robert Wachter, 
MD for reviewing the manuscript. 
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